Bioinformatics Data Analysis of Hippocampal CA1 Region in Alzheimer’s Disease Reversing GSEA Using Construction of Protein Interaction Network of Key Genes

Author:

Gao Wei1,Hu Baibo2,Zhang Fuyue3

Affiliation:

1. Jiangsu College of Nursing, Huaian, 223005, China

2. The People’s Hospital of Suzhou New District, Suzhou, 215129, China

3. Heilongjiang University of Chinese Medicine, Harbin, 150040, China

Abstract

We aimed to conduct bioinformatics analysis of genes differentially expressed in the cornu ammonis (CA1) region of the hippocampus of Alzheimer’s disease (AD) at differents tages and to explore AD and Molecular mechanisms of occurrence. Prepared from gene expression omnibus (GEO) database to obtain data from the gene chip of early, middle, and late AD, screened genes with significantly different expressions, and constructed protein–protein interaction (PPI). The network uses cyto NCA software to acquire key genes. The results were screened out from the gene chip of different stages of AD (GSE28146) and 412 genes with differential expression at different stages were screened, using STRING The PPI network relationship was constructed, cyto NCA was constructed and combined with the network topology analysis, and a total of 12 key genes were screened out; GO and Pathway enrichment analysis showed that it is closely related to the regulation of nitric oxide synthase activity, apoptosis, hypoxia response, neuroinflammation and other biological processes, and the main signaling pathways involved are Rap1, Ras and NF-KB, TNF, and PI3K-Akt. This study found that the imbalance of genes EGFR, CD44, CDH1, MMP2, VIM, PTPRC, CAV1 and SOCS3 were lowly expression in the occurrence of AD, while IL1B, BCL2L, KITLG and NOS1 was highly expression in AD. And they may be potential biological markers or drug targets to prevent and treat AD. Totally, the imbalance of genes and signaling pathways associated with neuro-inflammation may be an significant factor in the occurrence of AD, and they may be potential biological markers or drug targets for the prevention and treatment of AD.

Publisher

American Scientific Publishers

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3